Astrazeneca image

Profits slump at AstraZeneca

April 24, 2014
Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1

AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …

bhooshi_de_silva_ppd

PPD hires Bhooshi De Silva as senior VP



April 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, de silva

Contract research organisation Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior VP of corporate development and strategy …

sovaldi iamge

Sovaldi performs for Gilead

April 24, 2014
Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …

PrimeVigilance Zagreb Office, Croatia

PrimeVigilance Receives Queen’s Award for Enterprise

April 23, 2014

PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the …

Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

kadcyla image

NICE rejects Kadcyla

April 23, 2014
Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche

NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …

screen_shot_2014-04-23_at_08

Merck Millipore confirms chief executive and president

April 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Millipore, udit batra

Merck Millipore which is the life science division of Merck has named Dr Udit Batra as its incoming president and …

GSK and Novartis sign multi-billion dollar deal

April 23, 2014
Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines

GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …

AstraZeneca image

AstraZeneca ‘rejects Pfizer bid’

April 22, 2014
Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger

AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …

GSK image

GSK ‘to employ more doctors’

April 22, 2014
Medical Communications, Sales and Marketing China, Poland, gsk. doctors, shannon

GlaxoSmithKline is to employ more doctors as members of staff in a bid to ensure that the company is seen …

thierry_otin

Nanobiotix appoints head from Roche



April 22, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, nanobiotix, otin

France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply. Prior to joining Nanobiotix, …

Emmanuel image

Working Life: GE Healthcare’s Emmanuel Ligner

April 22, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GE Healthcare, Working Life, emmanuel linger

 How did you find your way into your current role? There have been various circumstances in my professional career that …

Biologics lift for UK

April 22, 2014
Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc

Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …

screen_shot_2014-04-14_at_10

arGEN-X appoints Evotec chief executive

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler

Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
  Lanthaler is currently …

Horsham image

Novartis ponders Horsham site future

April 14, 2014
Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site

Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …

GSK image

GSK bribery controversy spreads to Poland

April 14, 2014
Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq

Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …

Low image

How can ‘innovation’ be defined?

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma

Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …

Ema image

EMA to conduct major review into testosterone drugs

April 14, 2014
Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

The Gateway to Local Adoption Series

Latest content